Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Prostate Carcinoma”

732 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 732 results

Early research (Phase 1)Study completedNCT00739453
What this trial is testing

Dose-escalation Study of OSI-906 and Erlotinib (Tarceva®)

Who this might be right for
Advanced Solid Tumors
Astellas Pharma Inc 95
Large-scale testing (Phase 3)Study completedNCT01020448
What this trial is testing

Effect of Triptorelin (Decapeptyl®) 22.5 mg on Two Biomarkers in Patients With Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Ipsen 339
Testing effectiveness (Phase 2)Study completedNCT00140348
What this trial is testing

Dose Escalation and Efficacy Trial of GVAX® Prostate Cancer Vaccine

Who this might be right for
Prostate Cancer
Cell Genesys 80
Testing effectiveness (Phase 2)Study completedNCT01314118
What this trial is testing

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Who this might be right for
Prostate CancerProstatic Neoplasm
Janssen Biotech, Inc. 131
Early research (Phase 1)Study completedNCT03811652
What this trial is testing

A Multiple Ascending Dose Study of MEDI7247 in Advanced or Metastatic Solid Tumors

Who this might be right for
Non Small Cell Lung Cancer Squamous (NSCLC-Sq)Head and Neck Squamous Cell Carcinoma (HNSCC)Small Cell Lung Cancer (SCLC)+3 more
MedImmune LLC 8
Testing effectiveness (Phase 2)Ended earlyNCT00906243
What this trial is testing

RNActive®-Derived Therapeutic Vaccine

Who this might be right for
Hormone Refractory Prostate Cancer
University of Florida 6
Not applicableStudy completedNCT01078545
What this trial is testing

Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Prostate Cancer and Lower Urinary Tract Symptoms (LUTS)

Who this might be right for
Advanced Prostate CancerLower Urinary Tract Symptoms
Abbott 729
Testing effectiveness (Phase 2)Study completedNCT02268175
What this trial is testing

Enzalutamide/Leuprolide +/- Abiraterone/Pred in Prostate

Who this might be right for
Prostate AdenocarcinomaProstate CancerHigh Risk Prostate Cancer
Dana-Farber Cancer Institute 75
Post-approval studies (Phase 4)Ended earlyNCT02749825
What this trial is testing

Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Pharmatech 41
Testing effectiveness (Phase 2)Study completedNCT00940225
What this trial is testing

Study of Cabozantinib (XL184) in Adults With Advanced Malignancies

Who this might be right for
Solid TumorsCancer
Exelixis 730
Not applicableUnknownNCT03701659
What this trial is testing

TUPKRP Combined With MAB Therapy for LUTS/PCa

Who this might be right for
Advanced Prostate CancerLower Urinary Tract SymptomsQuality of Life+2 more
The Third Xiangya Hospital of Central South University 100
Testing effectiveness (Phase 2)Looking for participantsNCT06001255
What this trial is testing

ARTEMIS-003: HS-20093 in Patients With Metastatic Castrate-resistant Prostate Cancer (mCRPC) and Advanced Solid Tumors

Who this might be right for
Metastasis Castration Resistant Prostate Cancer(mCRPC)
Hansoh BioMedical R&D Company 120
Large-scale testing (Phase 3)UnknownNCT00796458
What this trial is testing

Androgen Ablation With or Without Docetaxel in Treating Patients With Advanced Prostate Cancer

Who this might be right for
PainProstate Cancer
A.O.U. San Giovanni Battista di Torino, Italy 200
Testing effectiveness (Phase 2)Looking for participantsNCT06172478
What this trial is testing

HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid TumorMelanomaHead and Neck Cancer+11 more
Daiichi Sankyo 740
Not applicableStudy completedNCT00540059
What this trial is testing

Evaluation of QoL, Tolerability and Use of Zoladex 10,8 SafeSystem for Advanced PCa - German IPEP Trial

Who this might be right for
Prostate Carcinoma
AstraZeneca 1,950
Testing effectiveness (Phase 2)Active Not RecruitingNCT06630325
What this trial is testing

A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer

Who this might be right for
Advanced Breast CarcinomaAdvanced Malignant Solid NeoplasmAdvanced Ovarian Carcinoma+11 more
OHSU Knight Cancer Institute 30
Early research (Phase 1)Study completedNCT01832870
What this trial is testing

Sipuleucel-T and Ipilimumab for Advanced Prostate Cancer

Who this might be right for
Prostate CancerCastrate Resistant Prostate Cancer
Prostate Oncology Specialists, Inc. 9
Early research (Phase 1)Ended earlyNCT04267939
What this trial is testing

ATR Inhibitor Elimusertib (BAY1895344) Plus Niraparib Phase 1b Study in Advanced Solid Tumors and Ovarian Cancer

Who this might be right for
Advanced Solid Tumors (Excluding Prostate Cancer)Ovarian Cancer
Bayer 14
Early research (Phase 1)Looking for participantsNCT06217822
What this trial is testing

First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)

Who this might be right for
Advanced Metastatic Castration-resistant Prostate CancerProstate Specific Membrane Antigen (PSMA) Expression
Bayer 198
Large-scale testing (Phase 3)Not Yet RecruitingNCT07200830
What this trial is testing

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

Who this might be right for
Metastatic Castration-Resistant Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IVB Prostate Cancer AJCC v8
Alliance for Clinical Trials in Oncology 1,524
Load More Results